SLC6A4 and major depressive disorder: The level of SLC6A4 DNA methylation was significantly higher at CpG2 in patients with MDD than in healthy controls (F(1,81)=8.365, P=0.005; Table 1), with medium effect size (Cohen's f=0.322, partial η2=0.094) as defined by Cohen.35